Zheming Lu

2.6k total citations · 1 hit paper
59 papers, 2.0k citations indexed

About

Zheming Lu is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Zheming Lu has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 22 papers in Molecular Biology and 22 papers in Immunology. Recurrent topics in Zheming Lu's work include CAR-T cell therapy research (19 papers), Immune Cell Function and Interaction (15 papers) and Epigenetics and DNA Methylation (10 papers). Zheming Lu is often cited by papers focused on CAR-T cell therapy research (19 papers), Immune Cell Function and Interaction (15 papers) and Epigenetics and DNA Methylation (10 papers). Zheming Lu collaborates with scholars based in China, United States and Ethiopia. Zheming Lu's co-authors include Roderick MacKinnon, Lise Heginbotham, Tatiana Abramson, Chaoting Zhang, Yang Ke, Dajun Deng, Yaqi Pan, Tao Ning, Ying Liu and Ruiping Xu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Zheming Lu

58 papers receiving 2.0k citations

Hit Papers

Mutations in the K+ channel signature sequence 1994 2026 2004 2015 1994 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mutations in the K+ channel signature sequence
    1994 660 citations Lise Heginbotham, Zheming Lu et al. Biophysical Journal profile →

Peers

Zheming Lu
Mark A. Hill United Kingdom
Ewald Hannappel Germany
Takahiro Isono Japan
Antonio Rodrı́guez Spain
Laurence Bianchini France
Lisa D. Belmont United States
Mikael Björklund United Kingdom
Liang Hong United States
Wayne Yu United States
Banafshé Larijani United Kingdom
Mark A. Hill United Kingdom
Zheming Lu
Citations per year, relative to Zheming Lu Zheming Lu (= 1×) peers Mark A. Hill

Countries citing papers authored by Zheming Lu

Since Specialization
Citations

This map shows the geographic impact of Zheming Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheming Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheming Lu more than expected).

Fields of papers citing papers by Zheming Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zheming Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheming Lu. The network helps show where Zheming Lu may publish in the future.

Co-authorship network of co-authors of Zheming Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zheming Lu. A scholar is included among the top collaborators of Zheming Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheming Lu. Zheming Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xinyu, et al.. (2025). Framework humanization enhances GM3(Neu5Gc)-targeting CAR-T cell function by reducing tonic signaling. Frontiers in Immunology. 16. 1697732–1697732.
2.
Zhang, Chaoting, Huirong Ding, Zhihua Tian, et al.. (2025). NKG2D/CD28 chimeric receptor boosts cytotoxicity and durability of CAR-T cells for solid and hematological tumors. Experimental Hematology and Oncology. 14(1). 52–52. 1 indexed citations
3.
Shen, Luyan, Chaoting Zhang, Likun Cui, et al.. (2022). Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activity. Cancer Letters. 538. 215710–215710. 50 indexed citations
4.
Shen, Luyan, et al.. (2022). Remodeling metabolic fitness: Strategies for improving the efficacy of chimeric antigen receptor T cell therapy. Cancer Letters. 529. 139–152. 19 indexed citations
5.
Zhang, Chaoting, et al.. (2022). TCR extracellular domain genetically linked to CD28, 2B4/41BB and DAP10/CD3ζ -engineered NK cells mediates antitumor effects. Cancer Immunology Immunotherapy. 72(3). 769–774. 10 indexed citations
6.
Cui, Likun, Chaoting Zhang, Huirong Ding, et al.. (2022). Clonal Distribution and Intratumor Heterogeneity of the TCR Repertoire in Papillary Thyroid Cancer With or Without Coexistent Hashimoto’s Thyroiditis. Frontiers in Immunology. 13. 821601–821601. 4 indexed citations
7.
Lei, Wen, Chaoting Zhang, Chunmei Yang, et al.. (2020). CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1–positive B-Cell Lymphoma. Clinical Cancer Research. 27(2). 473–484. 104 indexed citations
8.
Akhade, Sneha A., Zheming Lu, Tao Liang, et al.. (2017). Charge optimized many body (COMB) potentials for Pt and Au. Journal of Physics Condensed Matter. 29(22). 225901–225901. 15 indexed citations
9.
Wang, Shanshan, et al.. (2016). Identification and Characterization of Epstein-Barr Virus Genomes in Lung Carcinoma Biopsy Samples by Next-Generation Sequencing Technology. Scientific Reports. 6(1). 26156–26156. 26 indexed citations
10.
Qin, Sisi, Baozhen Zhang, Wei Tian, et al.. (2015). Kaiso mainly locates in the nucleus in vivo and binds to methylated, but not hydroxymethylated DNA.. Europe PMC (PubMed Central). 27(2). 148–55. 10 indexed citations
11.
Qin, Sisi, Qiang Li, Jing Zhou, et al.. (2014). Homeostatic Maintenance of Allele-Specific p16 Methylation in Cancer Cells Accompanied by Dynamic Focal Methylation and Hydroxymethylation. PLoS ONE. 9(5). e97785–e97785. 10 indexed citations
12.
Wang, Peng, et al.. (2013). Methylation of p16 CpG islands correlated with metastasis and aggressiveness in papillary thyroid carcinoma. Journal of the Chinese Medical Association. 76(3). 135–139. 23 indexed citations
13.
Li, Yong, Huirong Ding, Zheming Lu, et al.. (2011). Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential. BMC Cancer. 11(1). 121–121. 31 indexed citations
14.
15.
Li, Qiang, Xiuhong Wang, Zheming Lu, et al.. (2010). Polycomb CBX7 Directly Controls Trimethylation of Histone H3 at Lysine 9 at the p16 Locus. PLoS ONE. 5(10). e13732–e13732. 45 indexed citations
16.
Lu, Zheming, Lei Zhou, Patrick Killela, et al.. (2009). Glioblastoma Proto-oncogene SEC61γ Is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress. Cancer Research. 69(23). 9105–9111. 53 indexed citations
17.
Lu, Zheming, et al.. (2008). High-Level Expression of Glycoprotein D by a Dominant-Negative HSV-1 Virus Augments its Efficacy as a Vaccine against HSV-1 Infection. Journal of Investigative Dermatology. 129(5). 1174–1184. 15 indexed citations
18.
Yao, Feng, et al.. (2006). Highly Efficient Regulation of Gene Expression by Tetracycline in a Replication-Defective Herpes Simplex Viral Vector. Molecular Therapy. 13(6). 1133–1141. 22 indexed citations
19.
Liu, Baoguo, Zheming Lu, Hairong Jiang, et al.. (2005). Detection of human papillomavirus L1 -16 and -18 DNA and epstein-barr virus DNA in laryngeal carcinoma. Chinese Journal of Cancer Research. 17(2). 121–126. 2 indexed citations
20.
Heginbotham, Lise, Zheming Lu, Tatiana Abramson, & Roderick MacKinnon. (1994). Mutations in the K+ channel signature sequence. Biophysical Journal. 66(4). 1061–1067. 660 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark A. Hill Breakdown of academic impact, for papers by Ewald Hannappel Breakdown of academic impact, for papers by Takahiro Isono Breakdown of academic impact, for papers by Antonio Rodrı́guez Breakdown of academic impact, for papers by Laurence Bianchini Breakdown of academic impact, for papers by Lisa D. Belmont Breakdown of academic impact, for papers by Mikael Björklund Breakdown of academic impact, for papers by Liang Hong Breakdown of academic impact, for papers by Wayne Yu Breakdown of academic impact, for papers by Banafshé Larijani
Rankless by CCL
2026